References

1. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, et al. (2006) Functional gastroduodenal disorders. Gastroenterology 130: 1466-1479. View
2. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J (2001) Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121: 526-535. View
3. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J (1998) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115: 1346-1352. View
4. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J (2003) Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 98: 783-788. View
5. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, et al. (1996) Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 110: 1036-1042. View
6. Shindo T, Futagami S, Hiratsuka T, Horie A, Hamamoto T, et al. (2009) Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion 79: 65-72. View
7. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T (2005) Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol 20: 1652-1660. View
8. Yamawaki H, Futagami S, Shimpuku M, Sato H, Wakabayashi T, et al. (2014) Impact of sleep disorders, quality of life and gastric emptying in distinct subtypes of functional dyspepsia in Japan. J Neurogastroenterol Motil 20: 104-112. View
9. Wilmer A, Van Cutsem E, Andrioli A, Tack J, Coremans G, et al. (1998) Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut 42: 235-242. View
10. Tack J, Janssen P (2011) Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opin Investig Drugs 20: 701-712. View
11. Ogishima M, Kaibara M, Ueki S, Kurimoto T, Taniyama K (2000) Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach. J Pharmacol Exp Ther 294: 33-37. View
12. Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, et al. (2010) Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil 22: 618-627. View
13. Matsueda K, Hongo M, Tack J, Saito Y, Kato H (2012) A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 61: 821-828. View
14. Seto K, Sasaki T, Katsunuma K, Kobayashi N, Tanaka K, et al. (2008) Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil 20: 1051-1059. View
15. Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130: 1377-1390. View
16. McColl K1, Murray L, El-Omar E, Dickson A, El-Nujumi A, et al. (1998) Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 339: 1869-1874. View
17. Portincasa P, Altomare DF, Moschetta A, Baldassarre G, Di Ciaula A, et al. (2000) The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: A randomized, placebo-controlled ultrasonographic study. Am J Gastroenterol 95: 3444-3451. View
18. Chen CL, Lin HH, Chen MC, Huang LC (2005) Dyspeptic symptoms and water load test in patients with functional dyspepsia and reflux disease. Scand J Gastroenterol 40: 28-32. View
19. Shimpuku M, Futagami S, Kawagoe T, Nagoya H, Shindo T, et al. (2011) G-protein ß3 subunit 825CC genotype is associated with postprandial distress syndrome with impaired gastric emptying and with the feeling of hunger in Japanese. Neurogastroenterol Motil 23: 1073-1080. View
20. Svedlund J, Sjödin I, Dotevall G (1988) GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33: 129-134. View
21. Spielberger CD, Goursuch RL, Lushene RE (1983) Manual for the State Trait Anxiety Inventory. Mountain View, CA: Consulting Psychologist Press.
22. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ (2001) Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 96: 689-696. View
23. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyrén O, et al. (1996) Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 91: 660-673. View
24. Kusunoki H, Haruma K, Manabe N, Imamura H, Kamada T, et al. (2012) Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil 24: 540-545, e250-1. View
25. Matsueda K, Hongo M, Ushijima S, Akiho H (2011) A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration. Digestion 84: 261-268. View
26. Tack J, Masclee A, Heading R, Berstad A, Piessevaux H, et al. (2009) A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil 21: 272-280. View
27. Altan E, Masaoka T, Farre R, Tack J (2012) Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol 6: 533- 544. View
28. Nagahama K, Matsunaga Y, Kawachi M, Ito K, Tanaka T, et al. (2012) Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs. Neurogastroenterol Motil 24: 566-574. View
29. Taché Y, Bonaz B (2007) Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117: 33-40. View
30. Ehlert U, Nater UM, Böhmelt A (2005) High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. J Psychosom Res 59: 7-10. View
31. Nakajima T, Nawata H, Ito Y (2000) Z-338 a newly synthetized carboxyamide derivative, stimulates gastric motility through enhancing the excitatory neurotransmission. J Smooth Muscle Res 36: 69-81. View